Summary

1
Neisseria meningitidis remains an important cause of human disease. It is highly 2 adapted to the human host -its only known reservoir. Adaptations to the host 3 environment include many specific interactions with human molecules including 4 iron-binding proteins, components of the innate and adaptive immune systems,
5
and cell surface receptors such as the Epidermal Growth Factor Receptor (EGFR).
6
Interaction of the meningococcus with EGFR has been elucidated in some detail 7 and leads to intracellular signalling and cytoskeletal changes contributing to the 8 pathogenesis of the organism. Here, we show that the meningococcus also recruits
9
Fibroblast Growth Factor Receptor 1 (FGFR1) onto the surface of human blood
Introduction
16
Neisseria meningitidis, or the meningococcus, while normally a harmless 17 commensal of the human oropharynx, can occasionally cause devastating disease 18 including meningitis, sepsis, disseminated intravascular coagulation (DIC) and 19 multiple organ failure (Takada et al., 2016) . Penetration of meningococci through 20 the oropharyngeal epithelial mucosa and into the blood is a crucial step in the 21 development of sepsis and other systemic diseases, while penetration of the 22 blood-brain barrier (BBB) is a prerequisite for the development of meningitis 23 (Nassif, 1999 , Virji, 2009 ). Attachment to endothelial cells induces membrane
24
protrusions at the bacterial binding site and leads to the formation of specific 25 protein complexes known as cortical plaques underneath the bacterial colonies 26 (Merz et al., 1999 , Eugene et al., 2002 . The process by which these steps occur 27 is incompletely understood (Sokolova et al., 2004 , Yazdankhah et al., 2004 , Hill 28 et al., 2010 , but identified meningococcal adhesins include components of the 29 type IV pilus (PilC1, PilC2 and PilQ), the outer membrane proteins Opa, Opc,
30
Factor H-binding protein, PorA, PorB, HrpA, NadA, App and MspA, as well as 31 lipooligosaccharide (LOS) (Merz et al., 2000 , Hadi et al., 2001 , Turner et al., 2006 32 Morand et al., 2009) . Host cell receptors that have been identified include alpha 33 actinin, integrins, CEACAMS, CD46, Complement receptor 3, GP96 scavenger 34 receptor, laminin, platelet-activating factor, mannose receptor, Transferrin 35 receptor 1, Laminin receptor and Galectin-3 (Merz et al., 2000 , Morand et al., 36 2009 , Orihuela et al., 2009 , Quattroni et al., 2012 , Alqahtani et al., 2014 , Khairalla 37 et al., 2015 .
38
Fibroblast Growth Factor Receptors (FGFRs) are transmembrane proteins 39 that belong to the Receptor Tyrosine Kinase (RTK) family of signalling molecules.
40
This family consists of four members that are responsible for recognising all 22
41
Fibroblast Growth Factor molecules (FGFs) found in humans (Ornitz et al., 2001, 42 Turner et al., 2010 , Guillemot et al., 2011 (Miki et al., 1992 , Groth et al., 2002 , Eswarakumar et al., 2005 
53
Cell Adhesion Molecules (CAMs). This is followed by a transmembrane region and 54 a C-terminal cytoplasmic region containing 7 specific tyrosine residues (Ornitz et 55 al., 1992 , Reiland et al., 1993 , Cavallaro et al., 2004 , Francavilla et al., 2009 .
56
Binding of FGFs to FGFR leads to dimerisation of the receptor and activation of 57 tyrosine autophosphorylation, which in turn activates the receptor, leading to 58 activation of downstream signalling pathways (Mohammadi et al., 1992, 59 Mohammadi et al., 1996 , Lundin et al., 2003 , Zhang et al., 2006 . Previous studies 60 confirmed the importance of FGFR1 signalling and expression in maintaining the 61 integrity and differentiation of endothelial cells forming the microvasculature 62 (Kanda et al., 1996 , Gerwins et al., 2000 , Murakami et al., 2008 .
63
The possible role of FGFRs in infectious diseases has not been excessively 64 investigated, although FGF2 expression enhance Chlamydia trachomatis binding 65 and internalisation into epithelial cells (Kim et al., 2011 (Sahni et al., 2017) .
76
In a study of role of RTKs, and specifically EGFRs, in meningococcal infection 
81
Results
83
93
Meningococcal colonies co-localised with activated FGFR1 and 37LRP, up to 60%
94
of which was co-localised with FGFR1. This was significantly higher than co- 
126
There is a direct and specific interaction between FGFR1 IIIc and N. meningitidis.
127
To determine which isoforms of FGFR1 are expressed in HBMEC cells we performed
128
RT-PCR using cDNA generated from total RNA extracted from HBMECs. (Hoffmann et al., 2001 , Miller et al., 2012 , Slanina et al., 2012 . 
223
be involved in cytoskeletal rearrangement (Zhan et al., 1994 , Liu et al., 1999 .
224
However it was reported that mutation of Y766 in FGFR1 leads to higher level 225 activations of PLCγ which inhibits Src activation (Landgren et al., 1995) 
260
BSA/TBS at 4°C. Subsequent staining procedures were carried out in r 4%
261
(w/v)BSA/TBS. Briefly, coverslips incubated with primary antibody for 1 h were 262 washed with PBS followed by one wash with dH2O. Coverslips were then incubated with secondary antibody for 1 h in the dark followed by washes with PBS-Tween 
274
Antibody detecting 37LRP (A-7) was purchased from Santa Cruz Biotechnology
275
and antibody against 67LR (Mluc-5) was purchased from Thermo Scientific.
276
FGFR1-specific inhibitor SU5402 (Mohammadi et al., 1997) was purchased from
277
Calbiochem.
278
Fc-tagged FGFR1 IIIc (ca. 80 kDa), Fc-tagged FGFR2 IIIa TM (ca. 61.9 kDa) and
279
Fc-tag (ca. 29.26 kDa) were expressed and purified using a protein A column (S1).
280
FGFR1 siRNA transfection in HBMECs
281
Human FGFR1 siRNA (siGENOME SMART pool) and control scrambled siRNA were 
300
FGFR1 inhibition in HBMECs
301
HBMECs were serum-starved and treated with SU5402 (0.5 µM) 1 h prior to 
581
Chemical inhibition of FGFR1 activation also inhibited internalization of 582 meningococcal cells into HBMECs (p=0.0005 two-tailed unpaired t-test, n=7, the 583 error bars represent standard deviation of mean). 
584
